Objectives Given the rapidly evolving therapeutic landscape for type 2 diabetes (T2D) and chronic kidney disease (CKD), this study aimed to characterise the clinical profiles and real-world outcomes ...
Epic plans to expand the role of artificial intelligence across its EHR platform in 2026, with a focus on embedding AI directly into ...
Oracle still looks more like a hold than a sell, with fast‑growing cloud and AI revenue and a Street “Moderate Buy” rating with about 70% implied upside.
As health systems contend with financial pressures, workforce shortages and rising expectations for digital access, Meditech is positioning Expanse as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results